Cesca Therapeutics (KOOL) Narrows Q1 Loss

Cesca Therapeutics (NASDAQ: KOOL) reported Q1 EPS of ($0.08), versus ($0.14) reported last year. Revenue for the quarter came in at $3.7 million, versus $3.6 million reported last year.

For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c